1973Scandinavian Journal of RheumatologyRequires access

Double-Blind Crossover Trial of Naproxen and Placebo in Patients with Rheumatoid Arthritis

Robert F. Will kens

Open publisher page 14 citations

Abstract

The object of this study was a comparison of the effect of naproxen at the dose of 250 mg bid versus placebo for identical two-week periods in patients with established active rheumatoid arthritis.

About this research paper

What this paper is about

The object of this study was a comparison of the effect of naproxen at the dose of 250 mg bid versus placebo for identical two-week periods in patients with established active rheumatoid arthritis.

Why it matters

OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The object of this study was a comparison of the effect of naproxen at the dose of 250 mg bid versus placebo for identical two-week periods in patients with established active rheumatoid arthritis.

Key concepts: Medicine, Rheumatoid arthritis, Naproxen, Placebo, Crossover study, Double blind, Arthritis, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Double-Blind Crossover Trial of Naproxen and Placebo in Patients with Rheumatoid Arthritis — Research Paper | ScholarLens